Isolation of a novel strain of mycobacterium iranicum from a woman in the united states

Journal of Clinical Microbiology

Volumn 51, Issue 2, 2013, Pages 705-707

  Balakrishnan, Nandhakumar ^a   Tortoli, Enrico ^b   Engel, Susan L ^c   Breitschwerdt, Edward B ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; HEAT SHOCK PROTEIN 65; IMIPENEM; KANAMYCIN; LINEZOLID; MINOCYCLINE; MOXIFLOXACIN; RNA 16S; TIGECYCLINE; TOBRAMYCIN;

ABSCESS; ADULT; AEROSOL; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRONCHIECTASIS; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FEMALE; FOMITE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GRAM POSITIVE BACTERIUM; HUMAN; LUNG FUNCTION TEST; MINIMUM INHIBITORY CONCENTRATION; MONONUCLEAR CELL; MYCOBACTERIUM IRANICUM; NEW SPECIES; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIORBITAL EDEMA; PHARYNX DISEASE; PHYSICAL EXAMINATION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY EQUIPMENT; RESPIRATORY FAILURE; RNA SEQUENCE; SEQUENCE HOMOLOGY; SINUS CONGESTION; SPUTUM ANALYSIS; UNITED STATES; VERTIGO; VIRUS ENCEPHALITIS;

FEMALE; GENES, BACTERIAL; HUMANS; LUNG; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; SPUTUM; UNITED STATES;

EID: 84873020787     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02560-12     Document Type: Article

References (14)

1. Woods GL, Brown-Elliot BA, Conville PS, Desmond EP, Hall GS, Lin Pfyffer GGE, Ridderhof JC, Siddiqi SH, Wallace RJ Jr, Warren NG, Witebsky FG. 2011. Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes. Approved standard, 2nd ed. M24-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
2. McNabb A, Eisler D, Adie K, Amos M, Rodrigues M, Stephens G, Black WA, Isaac-Renton J. 2004. Assessment of partial sequencing of the 65- kilodalton heat shock protein gene (hsp65) for routine identification of mycobacterium species isolated from clinical sources. J. Clin. Microbiol. 42:3000 -3011.
3. Kirschner P, Springer B, Vogel U, Meier A, Wrede A, Kiekenbeck M, Bange FC, Bottger EC. 1993. Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J. Clin. Microbiol. 31:2882-2889.
4. Tortoli E. 2009. Clinical manifestations of nontuberculous mycobacteria infections. Clin. Microbiol. Infect. 15:906 -910.
5. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. 2009. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin. Infect. Dis. 49:e124-e129.
6. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, Saulson A, Hedberg K. 2010. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am. J. Respir. Crit. Care Med. 182:977-982.
7. Sontakke S, Cadenas MB, Maggi RG, Diniz PP, Breitschwerdt EB. 2009. Use of broad range16S rDNA PCR in clinical microbiology. J. Microbiol. Methods 76:217-225.
8. Neonakis IK, Gitti Z, Kontos F, Baritaki S, Petinaki E, Baritaki M, Liakou V, Zerva L, Spandidos DA. 2010. Mycobacterium arupense pulmonary infection: antibiotic resistance and restriction fragment length polymorphism analysis. Indian J. Med. Microbiol. 28:173-176.
9. Falkinham JO. 1996. Epidemiology of infection by nontuberculous mycobacteria. Clin. Microbiol. Rev. 9:177-215.
10. Olivier KN, Weber DJ, Wallace RJ, Faiz AR, Lee JH, Zhang Y, Brown- Elliott BA, Handler A, Wilson RW, Schecter MS, Edwards LJ, Chakraborti S, Knowles MR. 2003. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am. J. Respir. Crit. Care Med. 167:828-834.
11. Aksamit TR. 2002. Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin. Chest Med. 23:643- 653.
12. Shojaei H, Daley C, Gitti Z, Hashemi A, Heidarieh P, Moore ER, Daei Naser A, Russo C, van Ingen J, Tortoli E. 27 July 2012. M. iranicum sp. nov., a rapidly-growing scotochromogenic species isolated from clinical specimens on three different continents. Int. J. Syst. Evol. Microbiol. [Epub ahead of print.].
13. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Disease Subcommittee, American Thoracic Society, Infectious Diseases Society of America. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial disease. Am. J. Respir. Crit. Care Med. 175:367- 416.
14. Thomson RM. 2010. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg. Infect. Dis. 16:1576 -1583.